Please login to the form below

Sofinnova Partners

This page shows the latest Sofinnova Partners news and features for those working in and with pharma, biotech and healthcare.

Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs

Ashrafian, a partner at SV Health Investors, which co-led the Series A with Sofinnova Partners.

Latest news

Illumina sets up first ex-US accelerator site in Cambridge

Cambridge is of course also where Illumina was carrying out the DNA sequencing for the UK’s 100, 000 Genomes Project, in collaboration with Genomics England and other partners such as ... Illumina is joining forces with several venture firms for the
Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

The fundraising was co-led by leading healthcare investors Sofinnova Partners and 5AM Ventures, with Epidarex Capital and F-Prime Capital Partners also taking part.
Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

Its investors are Andera Partners (via Europe’s largest life sciences fund Biodiscovery V) and new backers, China’s Quan, plus existing investors Sofinnova Partners, IP Group, EMBL and Takeda Ventures.
News in brief, July 04, 2007

Sofinnova Partners, a French investment firm, led the Series A round, joined by additional backers Norway-based NeoMed Management and Bostonís MVM Life Science Partners. ... The lead investor was Special Situations Fund, while other investors were Fort
Boehringer Ingelheim and Ablynx sign GBP 136.5 million R&D agreement

Ablynx has raised over EUR 70 million (GBP 46.9 million) from an investor consortium which includes Abingworth Management (UK), Alta Partners (US), Biotech Fund Flanders (Belgium), Gilde Investment Management (Netherlands), ... GIMV (Belgium), KBC

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

Dr Martin Rothman joins Sofinnova Partners

Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. ... Rothman said: “I am thrilled to join Sofinnova Partners’ team as venture partner.
Kala Pharma appoints Fovea founder Bernard Gilly to board

Prior to his involvement with Fovea, Dr Gilly was a venture partner with Sofinnova Partners from 2000 to 2005.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Lead Copywriter: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Account Director – Creative Healthcare Communications: Competative

Medical Editor: Competitive

Healthcare Senior Account Manager: Competitive

Commercial Finance Director, Healthcare Marketing Communications...: up to £90K

Healthcare Account Director: Competitive

PMHub

Add my company

Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

Mistrust in medical research: a patient perspective: The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease: Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients: We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...